Dhabriya Polywood Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 11, 2025, 1:32 am

Competitors of Dhabriya Polywood Ltd

All Competitor Stocks of Dhabriya Polywood Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:10 pm

Below is a detailed analysis of the quarterly data for Dhabriya Polywood Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 62.09 Cr.. The value appears to be declining and may need further review. It has decreased from 63.47 Cr. (Mar 2025) to 62.09 Cr., marking a decrease of 1.38 Cr..
• For Expenses, as of Jun 2025, the value is 49.74 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 53.23 Cr. (Mar 2025) to 49.74 Cr., marking a decrease of 3.49 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.35 Cr.. The value appears strong and on an upward trend. It has increased from 10.24 Cr. (Mar 2025) to 12.35 Cr., marking an increase of 2.11 Cr..
• For OPM %, as of Jun 2025, the value is 19.89%. The value appears strong and on an upward trend. It has increased from 16.13% (Mar 2025) to 19.89%, marking an increase of 3.76%.
• For Other Income, as of Jun 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 1.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.24 Cr. (Mar 2025) to 1.37 Cr., marking an increase of 0.13 Cr..
• For Depreciation, as of Jun 2025, the value is 2.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.10 Cr. (Mar 2025) to 2.27 Cr., marking an increase of 0.17 Cr..
• For Profit before tax, as of Jun 2025, the value is 8.85 Cr.. The value appears strong and on an upward trend. It has increased from 7.06 Cr. (Mar 2025) to 8.85 Cr., marking an increase of 1.79 Cr..
• For Tax %, as of Jun 2025, the value is 25.99%. The value appears to be increasing, which may not be favorable. It has increased from 23.94% (Mar 2025) to 25.99%, marking an increase of 2.05%.
• For Net Profit, as of Jun 2025, the value is 6.54 Cr.. The value appears strong and on an upward trend. It has increased from 5.37 Cr. (Mar 2025) to 6.54 Cr., marking an increase of 1.17 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.04. The value appears strong and on an upward trend. It has increased from 4.96 (Mar 2025) to 6.04, marking an increase of 1.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:53 pm

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Below is a detailed analysis of the balance sheet data for Dhabriya Polywood Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2024) to 89.00 Cr., marking an increase of 18.00 Cr..
• For Borrowings, as of Mar 2025, the value is 53.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 53.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 28.00 Cr.. The value appears to be improving (decreasing). It has decreased from 29.00 Cr. (Mar 2024) to 28.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 181.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2024) to 181.00 Cr., marking an increase of 16.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 88.00 Cr. (Mar 2024) to 102.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 181.00 Cr.. The value appears strong and on an upward trend. It has increased from 165.00 Cr. (Mar 2024) to 181.00 Cr., marking an increase of 16.00 Cr..

Notably, the Reserves (89.00 Cr.) exceed the Borrowings (53.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Dhabriya Polywood Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 13.01 (Mar 24) to 16.65, marking an increase of 3.64.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 13.01 (Mar 24) to 16.65, marking an increase of 3.64.
• For Cash EPS (Rs.), as of Mar 25, the value is 24.62. This value is within the healthy range. It has increased from 19.38 (Mar 24) to 24.62, marking an increase of 5.24.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.33. It has increased from 76.05 (Mar 24) to 92.33, marking an increase of 16.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.33. It has increased from 76.05 (Mar 24) to 92.33, marking an increase of 16.28.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 217.21. It has increased from 195.52 (Mar 24) to 217.21, marking an increase of 21.69.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 35.19. This value is within the healthy range. It has increased from 29.13 (Mar 24) to 35.19, marking an increase of 6.06.
• For PBIT / Share (Rs.), as of Mar 25, the value is 27.22. This value is within the healthy range. It has increased from 22.76 (Mar 24) to 27.22, marking an increase of 4.46.
• For PBT / Share (Rs.), as of Mar 25, the value is 22.73. This value is within the healthy range. It has increased from 18.06 (Mar 24) to 22.73, marking an increase of 4.67.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 13.01 (Mar 24) to 16.65, marking an increase of 3.64.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 13.01 (Mar 24) to 16.65, marking an increase of 3.64.
• For PBDIT Margin (%), as of Mar 25, the value is 16.20. This value is within the healthy range. It has increased from 14.89 (Mar 24) to 16.20, marking an increase of 1.31.
• For PBIT Margin (%), as of Mar 25, the value is 12.53. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 12.53, marking an increase of 0.89.
• For PBT Margin (%), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 9.23 (Mar 24) to 10.46, marking an increase of 1.23.
• For Net Profit Margin (%), as of Mar 25, the value is 7.66. This value is within the healthy range. It has increased from 6.65 (Mar 24) to 7.66, marking an increase of 1.01.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.66. This value is below the healthy minimum of 8. It has increased from 6.65 (Mar 24) to 7.66, marking an increase of 1.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.03. This value is within the healthy range. It has increased from 17.10 (Mar 24) to 18.03, marking an increase of 0.93.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 23.03 (Mar 24) to 23.24, marking an increase of 0.21.
• For Return On Assets (%), as of Mar 25, the value is 9.95. This value is within the healthy range. It has increased from 8.55 (Mar 24) to 9.95, marking an increase of 1.40.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.21, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has decreased from 0.64 (Mar 24) to 0.53, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.36. It has decreased from 1.37 (Mar 24) to 1.36, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.82, marking an increase of 0.31.
• For Quick Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.79, marking an increase of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 4. It has increased from 2.31 (Mar 24) to 2.32, marking an increase of 0.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.84 (Mar 24) to 0.00, marking a decrease of 3.84.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.57 (Mar 24) to 0.00, marking a decrease of 2.57.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.16 (Mar 24) to 0.00, marking a decrease of 96.16.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.43 (Mar 24) to 0.00, marking a decrease of 97.43.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.85. This value is within the healthy range. It has increased from 6.20 (Mar 24) to 7.85, marking an increase of 1.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.71. This value is within the healthy range. It has increased from 3.77 (Mar 24) to 4.71, marking an increase of 0.94.
• For Enterprise Value (Cr.), as of Mar 25, the value is 384.04. It has increased from 321.51 (Mar 24) to 384.04, marking an increase of 62.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.63, marking an increase of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 10.08. This value is within the healthy range. It has decreased from 10.20 (Mar 24) to 10.08, marking a decrease of 0.12.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 1.44, marking an increase of 0.14.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.15 (Mar 24) to 0.00, marking a decrease of 96.15.
• For Price / BV (X), as of Mar 25, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 24) to 3.38, marking an increase of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 1.44, marking an increase of 0.14.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness